Notifications
Clear all
Topic starter
01/09/2026 2:50 pm
Overview
This presentation and panel discussion—hosted by Amy Seville alongside Margaret Nice and practitioner John Levak—breaks down a peer-reviewed study published in Cancer Medicine by researchers at MD Anderson Cancer Center (led by Drs. Lorenzo Cohen and Peiying Yang). The study evaluated the effects of the Bengston Energy Healing Method on pancreatic cancer models across in vitro cell lines, patient-derived organoids, and in vivo animal subjects.
Key Discussion Themes & Timestamps
-
Background and Paper Overview [01:32]Amy Seville introduces the publication, noting that it represents one of the first major studies from a premier institution (MD Anderson) evaluating the Bengston method under rigorous, controlled laboratory settings.
-
Multi-Layer Study Design [04:35]The experimental design featured four independent layers of evidence to ensure reproducibility:
-
Multiple human and murine pancreatic cancer cell lines.
-
Patient-derived mini-tumor organoids to mimic real human tissue response.
-
Orthotopic mouse models (both human-derived and mouse-derived tumors in the pancreas).
-
Three separate trained practitioners (John Levak, Laura Shalliker, Eric Bates) to eliminate single-healer bias.
-
-
Key Biological Findings & Specificity [06:12]Treated cancer cells exhibited significantly slower growth rates compared to both sham controls (untrained individuals mimicking hand motions) and incubator controls. Crucially, non-cancerous healthy control cells showed no adverse suppression, indicating cancer-specific targeting.
-
Clinical Context and Future Human Trials [01:04:02]The speakers clarify that while these preclinical laboratory results are notable, they do not constitute clinical proof of human efficacy. They emphasize the necessity of continuing conventional oncology care, discussing how MD Anderson is exploring complementary clinical trial protocols for pancreatic cancer patients.
-
Practitioner Experience During Trials [01:06:49]John Levak answers audience questions regarding his internal mental process during the lab tests—confirming he followed the standard rapid image cycling list without focusing on the disease or outcome, maintaining a neutral, detached stance.